quinacrine has been researched along with Malignant Mesothelioma in 2 studies
Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kulkarni, NS | 1 |
Vaidya, B | 1 |
Parvathaneni, V | 1 |
Bhanja, D | 1 |
Gupta, V | 1 |
Busacca, S | 1 |
Zhang, Q | 1 |
Sharkey, A | 1 |
Dawson, AG | 1 |
Moore, DA | 1 |
Waller, DA | 1 |
Nakas, A | 1 |
Jones, C | 1 |
Cain, K | 1 |
Luo, JL | 1 |
Salcedo, A | 1 |
Salaroglio, IC | 1 |
Riganti, C | 1 |
Le Quesne, J | 1 |
John, T | 1 |
Boutros, PC | 1 |
Zhang, SD | 1 |
Fennell, DA | 1 |
2 other studies available for quinacrine and Malignant Mesothelioma
Article | Year |
---|---|
Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.
Topics: Antineoplastic Agents; Apoptosis; Cell Movement; Cell Proliferation; Drug Repositioning; Humans; In | 2020 |
Transcriptional perturbation of protein arginine methyltransferase-5 exhibits MTAP-selective oncosuppression.
Topics: Biomarkers, Tumor; Cell Transformation, Neoplastic; Gene Deletion; Gene Expression Regulation, Neopl | 2021 |